Who Owns ARTL?

Artelo Biosciences, Inc. — Institutional Ownership & 13F Holdings

$3.51

-0.26 (-6.80%)

Market Cap

$2.5M

Shares Outstanding

2,124,772

Institutional Holders

8

Total Inst. Value

$75K

% of Float Held

QoQ Holder Change

+1

Institutional data as of Q1 2025

New Positions

2

Closed Positions

1

Increased

3

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GEODE CAPITAL MANAGEMENT, LLC$23K26,762
2CITADEL ADVISORS LLCNew$20K22,706
3SUSQUEHANNA INTERNATIONAL GROUP, LLPNew$18K20,388
4UBS Group AG$11K12,772
5Tower Research Capital LLC (TRC)$3K3,903
6BANK OF AMERICA CORP /DE/$027
7ROTHSCHILD INVESTMENT LLC$08
8MORGAN STANLEY$020

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
UBS Group AG-525$11K

Related Stocks

Frequently Asked Questions

How many institutional investors hold ARTL?

As of Q1 2025, 8 institutional investors report holding ARTL (Artelo Biosciences, Inc.) in their 13F filings.

Which hedge fund owns the most ARTL?

The largest institutional holder of ARTL is GEODE CAPITAL MANAGEMENT, LLC with $23K in shares.

Are institutions buying or selling ARTL?

This quarter, 2 institutions opened new positions in ARTL and 1 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.